What is the appropriate amoxicillin dose for acute otitis media in a 7‑year‑old child weighing 21.68 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosing for Acute Otitis Media in a 7-Year-Old Weighing 21.68 kg

Administer high-dose amoxicillin 1,950 mg per day (975 mg twice daily) for 10 days, calculated as 90 mg/kg/day divided into 2 doses. 1

Weight-Based Calculation

  • For this 21.68 kg child, the calculation is: 90 mg/kg/day × 21.68 kg = 1,951 mg/day, rounded to 1,950 mg total daily dose (975 mg every 12 hours). 1
  • The maximum single dose is 2,000 mg regardless of weight, so this dose is well within safe limits. 2

Rationale for High-Dose Therapy

  • High-dose amoxicillin (80–90 mg/kg/day) is the recommended first-line treatment for acute otitis media because it achieves middle ear fluid concentrations that exceed the minimum inhibitory concentration for intermediately resistant Streptococcus pneumoniae (penicillin MIC 0.12–1.0 μg/mL) and many highly resistant serotypes (penicillin MIC ≥2 μg/mL). 1
  • This dosing provides superior bacteriologic and clinical efficacy compared to standard-dose amoxicillin (40–45 mg/kg/day), with approximately 87% susceptibility of S. pneumoniae isolates to high-dose therapy versus 83% to standard-dose. 1
  • High-dose amoxicillin eradicates 92% of S. pneumoniae from middle ear fluid by days 4–6 of therapy, including penicillin-nonsusceptible strains. 3

Treatment Duration

  • Continue therapy for 10 days in children under 6 years of age with acute otitis media. 2
  • Clinical improvement (reduced pain, fever, irritability) should be evident within 48–72 hours of starting treatment. 4

When to Switch to Amoxicillin-Clavulanate

Switch to high-dose amoxicillin-clavulanate (90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate in 2 divided doses) if any of the following apply:

  • The child received amoxicillin in the previous 30 days. 1
  • No clinical improvement or worsening after 48–72 hours on amoxicillin alone. 1
  • Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome). 1
  • Severe presentation at onset (high fever ≥39°C, marked otalgia, bilateral disease in a child under 2 years). 4

The rationale for switching is that β-lactamase-producing Haemophilus influenzae (present in 58–82% of isolates) and Moraxella catarrhalis are resistant to amoxicillin alone but susceptible to amoxicillin-clavulanate. 1, 3

Practical Administration

  • Amoxicillin suspension is typically available as 400 mg/5 mL; for 975 mg per dose, administer 12.2 mL (approximately 12 mL) twice daily. 2
  • Administer doses every 12 hours to maintain therapeutic middle ear fluid concentrations throughout the dosing interval. 1
  • The twice-daily regimen has significantly lower rates of diarrhea (14%) compared to three-times-daily dosing (34%), with severe diarrhea or withdrawal rates of only 3% versus 8%. 5

Common Pitfalls to Avoid

  • Do not use standard-dose amoxicillin (40–45 mg/kg/day) for acute otitis media, as it fails to achieve adequate concentrations against resistant S. pneumoniae and leads to treatment failure rates of 20–25% when risk factors for resistant organisms are present. 4
  • Do not underdose based on age-based algorithms rather than weight-based calculations; this child requires the full 90 mg/kg/day, not a fixed pediatric dose. 2
  • Reassess at 48–72 hours if symptoms persist or worsen; failure to do so may result in complications from inadequately treated bacterial infection. 4
  • Verify suspension concentration before dispensing (e.g., 200 mg/5 mL versus 400 mg/5 mL) to avoid dosing errors. 2

Expected Outcomes

  • Clinical cure rates at end of therapy (days 12–14) are approximately 87% with high-dose amoxicillin. 5
  • Bacteriologic eradication of S. pneumoniae occurs in 92% of cases, including penicillin-resistant strains with MIC ≤2 μg/mL. 3
  • The high-dose regimen demonstrates 90–92% predicted clinical efficacy against the principal AOM pathogens (S. pneumoniae, H. influenzae, M. catarrhalis). 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicilina-Ácido Clavulánico Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.